Sherwin-Williams
SHW
$340.85
-1.16%
Sherwin-Williams is the world's largest manufacturer of paints and coatings, supplying professional painters, contractors, industrial manufacturers, and DIY consumers through its three primary segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group. As a market leader with over 4,800 company-owned stores and a dominant position in the North American architectural paint market, the company benefits from a strong brand and extensive distribution network. The current investor narrative centers on the company's ability to sustain growth amid a challenging macroeconomic environment, with attention focused on margin resilience, the impact of housing market trends on demand, and the company's strategic initiatives to expand its industrial coatings business.…
SHW
Sherwin-Williams
$340.85
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating: Hold. Sherwin-Williams is a high-quality business with a dominant market position and strong cash flows, but its elevated valuation and recent margin compression warrant caution. The analyst consensus is Buy with an average target of $379.60, implying 19.6% upside, but the stock's technical downtrend and negative relative strength suggest near-term headwinds.
Supporting Evidence: The company generated $2.905 billion in TTM free cash flow, providing a solid foundation. Revenue grew 6.81% YoY in Q1 2026, accelerating from prior quarters. However, the trailing P/E of 31.22x is above the 5-year average of ~25x, and the EV/EBITDA of 21.42x is elevated. The forward P/E of 23.87x is more reasonable, but still above the industry median. The dividend yield of 0.99% is modest, but the 47-year streak of increases adds stability.
Risks & Conditions: The biggest risks are margin compression (net margin down to 9.44% from 13.1% in Q3 2025) and high leverage (D/E 3.16x). If net margins recover above 12% and revenue growth sustains above 5%, the stock could re-rate higher, warranting an upgrade to Buy. Conversely, if margins fall below 8% or the housing market deteriorates sharply, a downgrade to Sell would be appropriate. Overall, the stock appears fairly valued relative to its history, but slightly overvalued versus peers, given the premium multiple.
Sign up to view all
SHW 12-Month Price Forecast
Sherwin-Williams is a fundamentally sound company with a wide moat, but the current valuation and margin trends suggest limited near-term upside. The base case of moderate growth and stable margins is most probable, with a 50% likelihood. The bull case requires a clear catalyst like margin recovery, while the bear case hinges on further deterioration in housing or margins. Given the neutral stance, investors should wait for a better entry point or confirmation of margin improvement before adding positions. The key factor to watch is the net margin trend in upcoming quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $389.60 and implied upside of +14.3% versus the current price.
Average Target
$389.60
0 analysts
Implied Upside
+14.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$340 - $420
Analyst target range
The stock is covered by 20 analysts, with a consensus recommendation of 'Buy' (mean rating 2.04 on a 5-point scale). The average target price is $379.60, implying 19.6% upside from the current price of $317.51. The distribution leans bullish, with no sell ratings in the provided data. Recent ratings include upgrades from RBC Capital (Outperform) and Citigroup (Buy), while UBS downgraded to Neutral. The target range spans from $330.00 (low) to $420.00 (high). The high target of $420 assumes strong execution, margin expansion, and potential market share gains, while the low target of $330 reflects concerns about housing market weakness and input cost inflation. The wide spread of $90 indicates high uncertainty about the company's future performance. The recent downgrade by UBS suggests some caution, but the overall consensus remains positive.
Drowning in data?
Find the real signal!
Bulls vs Bears: SHW Investment Factors
Sherwin-Williams presents a classic tension between a high-quality business with strong market position and cash flows, and a valuation that already prices in significant optimism. The bull case rests on the company's ability to sustain revenue growth and margin recovery, supported by analyst targets implying nearly 20% upside. However, the bear case highlights elevated leverage, margin compression, and a stock that has been in a persistent downtrend. The single most important factor is whether the company can stabilize and improve its net margins back toward 13% levels; if it does, the current P/E may be justified, but further compression could lead to multiple contraction and downside toward the 52-week low of $289.86. Currently, the evidence slightly favors the bear case given the technical weakness and margin trends, but the strong free cash flow and analyst support provide a floor.
Bullish
- Dominant Market Position: Sherwin-Williams is the world's largest paint manufacturer with over 4,800 company-owned stores, giving it unmatched distribution and brand strength. This scale supports pricing power and customer loyalty, evidenced by a stable gross margin of 49.07% in Q1 2026.
- Strong Free Cash Flow Generation: TTM free cash flow stands at $2.905 billion, providing ample resources for debt reduction, dividends, and strategic investments. The company has increased its dividend for 47 consecutive years, underscoring financial discipline.
- Analyst Consensus Buy with 19.6% Upside: The average analyst target of $379.60 implies a 19.6% upside from the current price of $317.51. With 20 analysts covering and a mean recommendation of 2.04 (Buy), sentiment is broadly positive.
- Revenue Growth Despite Macro Headwinds: Q1 2026 revenue grew 6.81% YoY to $5.667 billion, accelerating from 3.2% growth in Q1 2025. This demonstrates resilience in a challenging housing market and effective execution across segments.
Bearish
- Elevated Valuation vs. History and Peers: The trailing P/E of 31.22x is above the 5-year average of ~25x, and the EV/EBITDA of 21.42x is high for a specialty chemical company. This premium leaves little room for error if growth disappoints.
- High Debt-to-Equity and Low Current Ratio: Debt-to-equity is 3.16x, indicating significant leverage, while the current ratio of 0.87 suggests potential liquidity stress. This financial structure increases vulnerability to rising interest rates or economic downturns.
- Margin Compression Trend: Net margin declined from 13.1% in Q3 2025 to 9.44% in Q1 2026, and operating margin fell from 18.4% to 14.3% over the same period. This compression signals rising costs or competitive pressure.
- Negative Relative Strength and Downtrend: The stock has underperformed the S&P 500 by 23.14% over the past year and is trading near the bottom of its 52-week range (83.6% of range). Technical momentum remains negative, with a 1-month decline of 4.69%.
SHW Technical Analysis
Sherwin-Williams is in a sustained downtrend over the past year, with a 1-year price change of -6.67% and the stock currently trading at $317.51, which is 83.6% of its 52-week range (low $289.86, high $379.65). This positioning near the lower end of the range suggests bearish sentiment and potential value opportunity, but also reflects ongoing selling pressure. The stock has underperformed the S&P 500 significantly, with a relative strength of -23.14% over the past year. Short-term momentum is negative, with a 1-month price change of -4.69% and a 3-month change of -5.98%, indicating accelerating downside. The 1-month decline contrasts with the broader market's 0.78% gain over the same period, highlighting stock-specific weakness. The RSI is not provided, but the consistent negative momentum suggests oversold conditions may be approaching. The 52-week low of $289.86 serves as key support; a break below this level could signal further downside toward the next support zone. Resistance is at the 52-week high of $379.65, and a breakout above would indicate a reversal of the downtrend. Beta of 1.1 implies slightly higher volatility than the market, meaning the stock amplifies market moves by about 10%, which is moderate for a large-cap stock.
Beta
1.10
1.10x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$290-$380
Price range past year
Annual Return
+3.0%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | -1.5% | +0.2% |
| 3m | +7.2% | +3.7% |
| 6m | -3.9% | +8.0% |
| 1y | +3.0% | +18.2% |
| ytd | +4.0% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue growth has been steady but decelerating. In Q1 2026, revenue was $5.667 billion, up 6.81% year-over-year, compared to 6.3% growth in Q4 2025 and 3.2% in Q1 2025. The Paint Stores Group contributed $3.05 billion, Consumer Group $2.19 billion, and Global Finishes $1.72 billion, with the Paint Stores segment driving growth. The revenue trajectory remains positive but slowing, which may temper growth expectations. Profitability is solid, with net income of $534.7 million in Q1 2026 and a net margin of 9.44%, down from 13.1% in Q3 2025. Gross margin was 49.07%, relatively stable over recent quarters, indicating pricing power and cost control. Operating margin of 14.31% is healthy but below the 18.4% peak in Q3 2025, suggesting some margin compression. The company is profitable and generates strong cash flow, with TTM free cash flow of $2.905 billion. However, debt-to-equity is high at 3.16, and the current ratio of 0.87 indicates liquidity risk. ROE is robust at 55.86%, reflecting efficient use of equity, but the high leverage amplifies returns. Free cash flow yield is not directly provided, but the PCF ratio of 23.13 suggests reasonable cash flow valuation.
Quarterly Revenue
$5.7B
2026-03
Revenue YoY Growth
+6.8%
YoY Comparison
Gross Margin
49.1%
Latest Quarter
Free Cash Flow
$2.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 31.22x, while the forward P/E is 23.87x, implying the market expects earnings growth to reduce the multiple. The gap between trailing and forward P/E suggests anticipated earnings expansion, which aligns with analyst estimates of $16.16 EPS for the current year. Compared to the industry (Chemicals - Specialty), the stock trades at a premium. The industry average P/E is not provided, but the PS ratio of 3.39x and EV/EBITDA of 21.42x are elevated relative to typical chemical companies, reflecting Sherwin-Williams' market leadership and brand strength. Historically, the trailing P/E of 31.22x is above the 5-year average of around 25x, indicating the stock is trading at a premium to its own history. The current P/E is near the higher end of its historical range, suggesting the market is pricing in optimistic future growth. The PEG ratio is negative due to negative earnings growth expectations, which is a red flag, but this may be distorted by one-time items.
PE
31.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Sherwin-Williams carries a high debt-to-equity ratio of 3.16x, meaning the company is heavily leveraged, which amplifies earnings volatility and interest expense sensitivity. In Q1 2026, interest expense was $131.6 million, and with net income of $534.7 million, the interest coverage ratio is about 4.1x, adequate but not robust. The current ratio of 0.87 indicates that current liabilities exceed current assets, posing a liquidity risk if credit markets tighten. Additionally, net margin has compressed from 13.1% in Q3 2025 to 9.44% in Q1 2026, suggesting cost pressures or pricing challenges that could further erode profitability if not reversed.
Market & Competitive Risks: The stock's trailing P/E of 31.22x is a premium to its historical average and to many specialty chemical peers, making it vulnerable to valuation compression if growth slows. The beta of 1.1 implies slightly higher volatility than the market, so a broad market downturn could amplify losses. The housing market slowdown directly impacts demand for architectural paints, and while the company has diversified into industrial coatings, the Paint Stores Group (the largest segment) is sensitive to residential construction and renovation activity. Recent news of a dividend increase is positive, but the UBS downgrade to Neutral highlights that some analysts see limited near-term upside.
Worst-Case Scenario: In a severe recession where housing activity plummets and margins contract further, the stock could retest its 52-week low of $289.86, representing a potential downside of 8.7% from the current price of $317.51. However, if earnings disappoint and the multiple contracts to 25x (historical average), with estimated EPS of $16.16, the stock could fall to $404, which is above current levels, but if EPS falls to $14, the price could drop to $350. A more realistic worst-case, given the high debt, could see the stock decline to $289.86, a loss of about 8.7%, but if a credit event occurs, the downside could be larger, though unlikely for a dividend aristocrat.
FAQ
The key risks are: 1) Financial risk from high leverage (debt-to-equity of 3.16x) and a low current ratio of 0.87, which could strain liquidity in a downturn. 2) Margin compression risk, as net margin fell from 13.1% in Q3 2025 to 9.44% in Q1 2026, indicating cost pressures. 3) Housing market sensitivity, as the Paint Stores Group (largest segment) is tied to residential construction and renovation activity. 4) Valuation risk, with a trailing P/E of 31.22x above historical averages, making the stock vulnerable to multiple contraction if growth slows. The most severe risk is a combination of margin compression and housing recession, which could drive the stock to the 52-week low of $289.86.
The 12-month forecast for Sherwin-Williams is mixed, with a base case probability of 50% targeting a range of $330-$380, aligning with the analyst average of $379.60. The bull case (25% probability) sees the stock reaching $370-$420, driven by margin recovery and housing demand improvement. The bear case (25% probability) targets $290-$330, reflecting continued margin pressure and housing weakness. The most likely scenario is the base case, where revenue grows 5-6% and net margins stabilize around 10%. The stock's current price of $317.51 is near the lower end of the base case range, suggesting limited downside but requiring catalysts for upside.
Sherwin-Williams appears slightly overvalued relative to its own history and peers. The trailing P/E of 31.22x is above the 5-year average of approximately 25x, and the EV/EBITDA of 21.42x is elevated for the specialty chemicals industry. The forward P/E of 23.87x is more reasonable, implying that the market expects earnings growth to reduce the multiple. Compared to the industry, the stock commands a premium due to its market leadership and brand strength. The PEG ratio is negative due to negative earnings growth expectations, which is a red flag, but this may be distorted by one-time items. Overall, the market is pricing in optimistic future growth, leaving limited margin of safety if results disappoint.
Sherwin-Williams is a good stock to buy for long-term investors who value stability and income, but it may not be ideal for those seeking near-term capital gains. The analyst consensus is Buy with an average target of $379.60, implying 19.6% upside from the current price of $317.51. However, the stock is trading at a trailing P/E of 31.22x, above its historical average, and has been in a downtrend, underperforming the S&P 500 by 23.14% over the past year. The biggest downside risk is further margin compression, which could push the stock toward the 52-week low of $289.86. For risk-tolerant investors with a 3-5 year horizon, the strong free cash flow and dividend growth provide a margin of safety. For short-term traders, the negative momentum suggests waiting for a clearer bottom.
Sherwin-Williams is more suitable for long-term investment due to its stable business model, strong free cash flow, and consistent dividend growth (47 consecutive years of increases). The beta of 1.1 indicates moderate volatility, but the stock's 1-year decline of 6.67% versus the S&P 500's gain of 16.47% shows it can underperform in risk-off environments. Short-term traders may find the negative momentum challenging, as the stock has been in a downtrend with a 1-month decline of 4.69%. For long-term investors, a minimum holding period of 3-5 years is recommended to ride out housing cycles and benefit from compounding dividends. The current valuation near the 52-week low provides a reasonable entry point for patient investors.